In starved antibiotic field, Melinta soars as FDA grants speedy drug review

In starved antibiotic field, Melinta soars as FDA grants speedy drug review

Submitted by admin on June 20, 2019 - 9:53am
Source: 
Endpoints
News Tags: 
Melinta Therapeutics
antibiotics
Baxdela
community-acquired bacterial pneumonia
FDA
priority review
Headline: 
In starved antibiotic field, Melinta soars as FDA grants speedy drug review
snippet: 

On Wednesday, Melinta Therapeutics said its approved antibiotic Baxdela had been granted priority review for use in community-acquired bacterial pneumonia (CAPB). The FDA is expected to make its decision by October 24. 

Do Not Allow Advertisers to Use My Personal information